Literature DB >> 20439949

Intermittent preventive treatment for malaria in sub-saharan African: a halfway technology or a critical intervention?

Joseph M Vinetz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20439949      PMCID： PMC2861375          DOI： 10.4269/ajtmh.2010.825editorial

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  10 in total

1.  Implementing intermittent preventive treatment in infants.

Authors:  Alexandra de Sousa; Peter Salama; Mickey Chopra
Journal:  Lancet       Date:  2010-01-09       Impact factor: 79.321

2.  Intermittent preventive treatment of malaria in infancy.

Authors:  Rose McGready
Journal:  Lancet       Date:  2009-09-16       Impact factor: 79.321

3.  Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.

Authors:  Jaishree Raman; Francesca Little; Cally Roper; Immo Kleinschmidt; Yasmin Cassam; Rajendra Maharaj; Karen I Barnes
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

4.  The technology of medicine.

Authors:  L Thomas
Journal:  N Engl J Med       Date:  1971-12-09       Impact factor: 91.245

5.  Return of chloroquine antimalarial efficacy in Malawi.

Authors:  Miriam K Laufer; Phillip C Thesing; Nicole D Eddington; Rhoda Masonga; Fraction K Dzinjalamala; Shannon L Takala; Terrie E Taylor; Christopher V Plowe
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

Review 6.  Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.

Authors:  John J Aponte; David Schellenberg; Andrea Egan; Alasdair Breckenridge; Ilona Carneiro; Julia Critchley; Ina Danquah; Alexander Dodoo; Robin Kobbe; Bertrand Lell; Jürgen May; Zul Premji; Sergi Sanz; Esperanza Sevene; Rachida Soulaymani-Becheikh; Peter Winstanley; Samuel Adjei; Sylvester Anemana; Daniel Chandramohan; Saadou Issifou; Frank Mockenhaupt; Seth Owusu-Agyei; Brian Greenwood; Martin P Grobusch; Peter G Kremsner; Eusebio Macete; Hassan Mshinda; Robert D Newman; Laurence Slutsker; Marcel Tanner; Pedro Alonso; Clara Menendez
Journal:  Lancet       Date:  2009-09-16       Impact factor: 79.321

7.  Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.

Authors:  Roly D Gosling; Samwel Gesase; Jacklin F Mosha; Ilona Carneiro; Ramadhan Hashim; Martha Lemnge; Frank W Mosha; Brian Greenwood; Daniel Chandramohan
Journal:  Lancet       Date:  2009-09-16       Impact factor: 79.321

Review 8.  Intermittent preventive therapy for malaria: progress and future directions.

Authors:  Martin P Grobusch; Andrea Egan; Roly D Gosling; Robert D Newman
Journal:  Curr Opin Infect Dis       Date:  2007-12       Impact factor: 4.915

9.  Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria.

Authors:  Wendy Prudhomme O'Meara; David L Smith; F Ellis McKenzie
Journal:  PLoS Med       Date:  2006-04-04       Impact factor: 11.069

Review 10.  Intermittent presumptive treatment for malaria.

Authors:  Nicholas J White
Journal:  PLoS Med       Date:  2005-01       Impact factor: 11.069
  10 in total
  5 in total

Review 1.  Strategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosis.

Authors:  Kerstin A Wolff; Liem Nguyen
Journal:  Expert Rev Anti Infect Ther       Date:  2012-09       Impact factor: 5.091

2.  Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children.

Authors:  Amanda Ross; Nicolas Maire; Elisa Sicuri; Thomas Smith; Lesong Conteh
Journal:  PLoS One       Date:  2011-04-07       Impact factor: 3.240

3.  Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants.

Authors:  Ulrike Buchholz; Robin Kobbe; Ina Danquah; Philipp Zanger; Klaus Reither; Harry H Abruquah; Martin P Grobusch; Peter Ziniel; Jürgen May; Frank P Mockenhaupt
Journal:  Malar J       Date:  2010-08-26       Impact factor: 2.979

4.  Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.

Authors:  Asia Mohammed; Arnold Ndaro; Akili Kalinga; Alphaxard Manjurano; Jackline F Mosha; Dominick F Mosha; Marco van Zwetselaar; Jan B Koenderink; Frank W Mosha; Michael Alifrangis; Hugh Reyburn; Cally Roper; Reginald A Kavishe
Journal:  Malar J       Date:  2013-11-14       Impact factor: 2.979

5.  Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania.

Authors:  Reginald A Kavishe; Robert D Kaaya; Sidsel Nag; Camilla Krogsgaard; Jakob Ginsbak Notland; Adellaida A Kavishe; Deus Ishengoma; Cally Roper; Michael Alifrangis
Journal:  Malar J       Date:  2016-06-23       Impact factor: 2.979
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.